Nanoscale products pose ethical, legal, and policy challenges to governing the use of products that integrate multiple mechanisms of therapeutic action.
AMA J Ethics. 2019;21(4):E347-355. doi:
10.1001/amajethics.2019.347.
International debate about human genome editing governance has undergone a paradigm shift and suggests that inclusive public deliberation is still important.
AMA J Ethics. 2019;21(12):E1065-1070. doi:
10.1001/amajethics.2019.1065.
Shailendra Prasad, MBBS, MPH, Fatima Alwan, MS, Jessica Evert, MD, Tricia Todd, MPH, and Fred Lenhoff, MA
Short-term experiences in global health are common ways trainees engage in global health activities. Professional societies take active roles in addressing these ethical challenges.
AMA J Ethics. 2019;21(9):E742-748. doi:
10.1001/amajethics.2019.742.